James E. Krook

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand et al. · Cancer · 1990 · 207 citations · Full text

Medicine, Oncology, Pharmacology +10

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

James E. Krook, Michael J. O' Connell, H. Samuel Wieand et al. · Cancer · 1991 · 101 citations · Full text

Medicine, Oncology, Surgery +13

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol

Lynn C. Hartmann, James N. Ingle, Lester E. Wold et al. · Cancer · 1994 · 96 citations · Full text

Medicine, Oncology, Pathology +13

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma

Jan C. Buckner, Loren D. Brown, John W. Kugler et al. · Journal of neurosurgery · 1995 · 68 citations

Medicine, Oncology, Pharmacology +17

Octreotide as first-line treatment for women with metastatic breast cancer

James N. Ingle, Carl G. Kardinal, Vera J. Suman et al. · Investigational New Drugs · 1996 · 19 citations

Medicine, Oncology, Pharmacology +14